Public case informationLast updated
Boostrix advertising class action settlement
GlaxoSmithKline · Boostrix vaccine advertising · Settlement Reached
About this case
Consumers alleged that GlaxoSmithKline’s “Big Bad Cough” advertising campaign for the Boostrix whooping cough vaccine misleadingly suggested that the vaccine could prevent transmission of whooping cough. GlaxoSmithKline agreed to settle the class action, with claims due by June 8, 2026.
Case overview
- Defendant company
- GlaxoSmithKline
- Product or service
- Boostrix vaccine advertising
- Case name
- DeCostanzo v. GlaxoSmithKline plc et al.
- Case status
- Settlement Reached
- Lawsuit type
- Consumer
- Reported harm
- False Advertising
Important dates
- Boostrix advertising settlement claim
Participation information
Boostrix advertising settlement claim
People who viewed the “Big Bad Cough” campaign between May 20, 2016, and May 20, 2020, and either lived in New York or received Boostrix in New York.
A valid claim could provide $50 with proof of vaccination or $10 without qualifying proof.
- Type
- Settlement Claim
- Status
- Deadline passed
- Payout
- $50 with proof of vaccination or $10 without qualifying proof of vaccination.
- Reported proof requirement
- Unclear
Sources
- Class-action settlements involving Boostrix advertising and Trader Joe’s receipts
Yahoo! Finance ·
- Consumer Class-Action Settlements and Claim Deadlines
Detroit Free Press ·